Scopus Biopharma, Inc. (SCPS)
|Net Income (ttm)||-10.41M|
|Trading Day||January 15|
|Day's Range||12.96 - 13.50|
|52-Week Range||5.92 - 33.96|
NEW YORK, Dec. 29, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the appointment of additional members to its Board of Directors. Scopus is a biopharmaceutical comp...
NEW YORK, Dec. 18, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of its initial public offering. The underwriters for the initial public offering exerci...
Scopus BioPharma (SCPS) stock is soaring higher as the company's IPO continues on Thursday and InvestorPlace has all the details. The post SCPS Stock: 14 Things to Know About the Scopus BioPha...
Scopus Biopharma Inc (NASDAQ: SCPS) shares, which debuted on the Nasdaq Wednesday, are ripping higher. What Happened: New York-based Scopus, a biopharma company developing therapeutics for ser...
Shares of Oriental Culture Holding Ltd. more than tripled (up 204.3%) in premarket trading Thursday, as the Hong Kong-based provider of collectibles and artwork e-commerce services heads for i...
NEW YORK, Dec. 15, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the pricing of its initial public offering. The company's common stock is set to begin trading Wedn...
Scopus Biopharma is a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. To achieve our mission, we seek to capitalize on ground-breaking scientific and medical discoveries at some of the world’s foremost academic and research institutions. Our strategic partners, City of Hope, NIH and Hebrew University and their respective scientists, medical doctors and other senior researchers with whom we are working at each of our strategic partners are leaders in their resp... [Read more...]
|IPO Date |
Dec 16, 2020
Morris C. Laster, M.D.
|Stock Exchange |
|Ticker Symbol |